logo
Plus   Neg
Share
Email

Pfizer Names CEO Albert Bourla To Succeed Ian Read As Chairman - Quick Facts

Pfizer Inc. (PFE) announced Friday that its Board of Directors has unanimously elected Chief Executive Officer Dr. Albert Bourla to succeed Ian Read as Chairman of the Board of Directors, effective January 1, 2020. Read has chosen to retire on December 31, 2019.

Bourla will also retain the CEO role, to which he succeeded Read on January 1, 2019. Previously, he served as chief operating officer from on January 1, 2018 and led Pfizer's Innovative Health business prior to that. In January 2014, he became the group president of the Vaccines, Oncology and Consumer Healthcare business unit.

Read retires form Pfizer after serving the company for the past 41 years. He joined Pfizer in 1978 and was named CEO in December 2010, and Chairman of the Board of Directors in December 2011.

The company said the naming of Albert as Chairman is the result of a systemic and comprehensive succession plan undertaken by the board several years ago.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Airbnb has introduced few new rules to control parties and nuisances amidst the backlash the service received after the Halloween shooting at an Airbnb rental in a San Francisco. San Francisco-based Airbnb said it is banning "open invite" parties at all of its accommodations. The company is also banning... The U.S. Food and Drug Administration has approved three generic versions of Novartis' Gilenya capsule for treating relapsing forms of multiple sclerosis. "Approving safe and effective generics so patients have more treatment options continues to be a priority for the FDA," said Janet Woodcock, director... Shares of Upscale furniture chain RH (RH) are on a tear, on the heels of an upbeat annual forecast. Today, the stock set a new all-time high of $239.88.The stock is up more than 20% from its Dec 3 opening price of $196.66, and currently trading at $237.8, and nearly three-times its 52-week low of $84.11....
Follow RTT
>